Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,374.75", "chg": -3.25, "chgp": "-0.06%", "dir": -1, "prev_price": "5,378.00", "mcapval": "64,087.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "Jun 19, 03:30 PM", "curr_time": "03:30 AM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "87.47 k", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4053406", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_valuationdot_4053406.png", "date": "2026-06-15 08:01:48", "description": "Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade amid evolving market dynamics. Despite a modest day change of -0.10%, the pharmaceutical mid-cap’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more compelling entry point relative to its historical averages and peer group, prompting a downgrade in its overall Mojo Grade to Sell from Hold as of 11 May 2026." }, { "title": "Alkem Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4052747", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_mojoScore_4052747.png", "date": "2026-06-14 10:10:29", "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Alkem Laboratories Declines 4.48%: 3 Key Technical Shifts Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-448-3-key-technical-shifts-shape-the-week-4052049", "imagepath": "", "date": "2026-06-13 16:20:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Significant open interest surge amid bearish price action</p>\n <p><strong>1 June:</strong> Technical momentum shifts to sideways with mixed signals</p>\n <p><strong>2 June:</strong> Mildly bearish technical shift amid market volatility</p>\n <p><strong>5 June:</strong> Week closes at Rs.5,251.25 (-4.48%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,497.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,2..." }, { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4037492", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_valuationdot_4037492.png", "date": "2026-06-08 08:01:51", "description": "Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions and relative valuation improvements within the Pharmaceuticals & Biotechnology sector, offering investors a fresh perspective on the stock’s price attractiveness." }, { "title": "Alkem Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4033502", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_mojoScore_4033502.png", "date": "2026-06-03 10:11:05", "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-market-volatility-4029727", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_technicaldot_4029727.png", "date": "2026-06-02 08:08:54", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, and moving averages, signal a cautious outlook as the stock price declined by 3.29% on 2 Jun 2026, closing at ₹5,317 from the previous close of ₹5,497.80." }, { "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Bearish Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-bearish-price-action-4026709", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_oi_spurts_by_underlying_4026709.png", "date": "2026-06-01 14:00:15", "description": "Alkem Laboratories Ltd has experienced a notable 10.22% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with a decline in share price and increased delivery volumes, suggests a complex interplay of investor positioning and potential directional bets in the pharmaceutical sector." }, { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4025292", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlkemLaboratori_technicaldot_4025292.png", "date": "2026-06-01 08:04:08", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent upgrade in price action, the stock’s overall technical grade has been downgraded to Sell, signalling caution for investors amid mixed signals from MACD, RSI, moving averages, and other momentum oscillators." }, { "title": "Alkem Laboratories Gains 1.70%: 5 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-gains-170-5-key-factors-driving-the-weeks-momentum-4022894", "imagepath": "", "date": "2026-05-30 13:05:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens at Rs.5,400.05, declines slightly amid Sensex rally</p>\n <p><strong>26 May:</strong> Continued minor decline to Rs.5,379.00 with Sensex dipping marginally</p>\n <p><strong>27 May:</strong> Significant open interest surge and 1.36% price gain to Rs.5,452.25</p>\n <p><strong>29 May:</strong> Intraday high of Rs.5,793.5 with 5.35% close gain at Rs.5,497.80</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,405.70</div></div>\n <div class=\"stat-item\"><div cla..." } ], "total": 593, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "15-Jun-2026", "details": "Please find attached herewith Analyst / Investor Meet - Intimation.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "10-Jun-2026", "details": "Please find attached herewith Analyst / Investor Meet - Intimation.", "source": "BSE" }, { "caption": "Dislcosure letter under Regulation 11(5) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011.", "datetime": "03-Jun-2026", "details": "Samprada & Nanhamati Singh Family Trust has submitted a letter to Exchange on amendment to trust deed under Regulation 11(5) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26", "dt": "2026-02-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Significant open interest surge amid bearish price action

1 June: Technical momentum shifts to sideways with mixed signals

2 June: Mildly bearish technical shift amid market volatility

5 June: Week closes at Rs.5,251.25 (-4.48%)

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-08 08:01:51

Alkem Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions and relative valuation improvements within the Pharmaceuticals & Biotechnology sector, offering investors a fresh perspective on the stock’s price attractiveness.

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-06-03 10:11:05

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Market Volatility

2026-06-02 08:08:54

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, and moving averages, signal a cautious outlook as the stock price declined by 3.29% on 2 Jun 2026, closing at ₹5,317 from the previous close of ₹5,497.80.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Bearish Price Action

2026-06-01 14:00:15

Alkem Laboratories Ltd has experienced a notable 10.22% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with a decline in share price and increased delivery volumes, suggests a complex interplay of investor positioning and potential directional bets in the pharmaceutical sector.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-01 08:04:08

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent upgrade in price action, the stock’s overall technical grade has been downgraded to Sell, signalling caution for investors amid mixed signals from MACD, RSI, moving averages, and other momentum oscillators.